Global Biopsy Devices Market

Biopsy Devices Market was valued at USD 2.51 Bn. in 2025 and is expected to reach USD 3.53 Bn. at a CAGR of 4.98% during the forecast period 2026-2032.

Biopsy devices are several pieces of equipment used to surgically remove tissues from an organ. Surgeons, radiologists, cardiologists, and other medical professionals use them to determine the existence and degree of malignant and inflammatory disorders. Some of the most widely used biopsy equipment include aspiration needles, forceps, and localization wires. These instruments are utilized in MRI-guided, needle-based, core, and vacuum-assisted biopsies of the liver, lungs, kidneys, and breasts, among other body areas. They're used in a wide range of healthcare settings, including medical clinics, diagnostic centers, and hospitals.

The report explores the Global Biopsy Devices Market segments (Product type, Application, Guidance Technique, End User, and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances occurring across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2020 to 2025. The report investigates the drivers, limitations, prospects, and barriers of the Global Biopsy Devices Market. This MMR report includes investor recommendations based on a thorough examination of the Global Biopsy Devices Market contemporary competitive scenario.

To know about the Research Methodology :- Request Free Sample Report

Biopsy Devices Market Dynamics:

The Global Biopsy Devices Market is likely to benefit from rising demand for less invasive operations and disposable biopsy devices. Patients and healthcare practitioners are becoming more interested in technologically improved biopsy guided devices, such as vacuum-assisted guns. The advent of cost-effective and improved devices, as well as the growing elderly population, are expected to fuel the growth of the Global Biopsy Devices Market. The need for reliable diagnostic procedures is growing in response to rising cancer-related spending. Governments and healthcare regulatory agencies all over the world are continually working to bring down the exorbitant expenses connected with cancer treatment. Patients in emerging countries' primary and secondary healthcare centres are encouraged to have regular diagnostic exams. The use of biopsy devices results in a lower number of hospital stays and a shorter recovery time. The rise is accompanied by an increase in the incidence of cancers such as breast, prostate, and lung, as well as significant technological advancements. Furthermore, increased awareness of chronic disease diagnosis is likely to boost demand for biopsy instruments over the forecast period.

The market's strong growth can be ascribed to rising cancer rates, advantageous reimbursement programmes, and a shift toward less invasive procedures. More advanced, effective, and safe biopsy methods are being developed as the patient pool grows. Various government and healthcare organisation activities aimed at cancer treatment and diagnosis would help the market develop even faster throughout the forecast period. Increasing healthcare spending and substantial research and development (R&D) activities are also having a beneficial impact on the industry.The use of biopsy equipment is being fueled by rapid technology improvements such as vacuum assisted guns, 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies. More people are choosing for biopsy procedures since they can be used to diagnose practically every organ.

Biopsy Devices Market Segment Analysis:

Based on Product Type, the Needle-based Biopsy Instruments segment dominated the global biopsy devices market in 2025 due to their high precision, minimal invasiveness, and broad clinical usage. These instruments are widely used for obtaining accurate tissue samples for diagnostic purposes, particularly in oncology and pathology. Their ability to reduce patient discomfort and recovery time compared to surgical biopsy procedures significantly increased their adoption in hospitals and diagnostic centers. Continuous technological advancements such as automated core biopsy needles and vacuum-assisted biopsy systems further enhanced diagnostic accuracy and procedural efficiency. The growing prevalence of cancer and increasing demand for early disease detection continued to drive the demand for needle-based biopsy instruments.

Based on Application, the Breast Biopsy segment held the largest share of the biopsy devices market in 2025. The dominance of this segment is primarily attributed to the rising global incidence of breast cancer and increasing awareness regarding early detection and screening. Healthcare providers increasingly utilized advanced biopsy techniques for accurate diagnosis and treatment planning. Technological developments in minimally invasive biopsy procedures and image-guided breast biopsy techniques further supported the growth of this segment.

Based on Guidance Technique, the Ultrasound-Guided Biopsy segment dominated the market in 2025 due to its real-time imaging capability, cost effectiveness, and widespread availability in healthcare facilities. Ultrasound guidance allows physicians to precisely locate suspicious tissue and obtain accurate samples with minimal complications. The increasing use of ultrasound-guided biopsy procedures in breast, liver, thyroid, and prostate diagnostics significantly contributed to the growth of this segment.

Based on End-User, the Hospitals and Diagnostic Centers segment accounted for the largest share of the biopsy devices market in 2025. This dominance is driven by the availability of advanced medical infrastructure, skilled healthcare professionals, and a high volume of diagnostic procedures conducted in hospital settings. Hospitals increasingly adopted advanced biopsy technologies to support early disease detection and improve patient outcomes. Additionally, the growing number of specialized diagnostic centers and increasing demand for minimally invasive procedures further supported the expansion of this segment.

Biopsy Devices Market Regional Insights:

In 2025, North America dominated the global biopsy devices market, accounting for around 32%–41% of the global market share, supported by advanced healthcare infrastructure, high healthcare expenditure, and the presence of major medical device manufacturers. The United States led the regional market due to the high prevalence of cancer and strong adoption of advanced diagnostic technologies. Continuous innovation and strong research and development activities by companies such as Medtronic, Hologic, and Becton, Dickinson and Company further strengthened the market. In addition, favorable reimbursement policies, growing awareness regarding early disease detection, and increasing adoption of minimally invasive and image-guided biopsy procedures continued to support the region’s leadership in the global biopsy devices market.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Biopsy Devices Market dynamic, structure by analyzing the market segments and projecting the Global Biopsy Devices Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Biopsy Devices Market make the report investor’s guide.

Biopsy Device Market: Recent Developments

Recent Industry Developments (2025–2026)

Biopsy Device Market Ecosystem

Biopsy Devices Market Scope: Inquire before buying

Biopsy Devices Market by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)

South America

Biopsy Devices Market Key Players

1. Medtronic plc
2. Becton, Dickinson and Company
3. Boston Scientific
4. Danaher Corporation
5. Olympus Corporation
6. Fujifilm Holdings Corporation
7. Hologic, Inc.
8. Cardinal Health Inc.
9. B. Braun Melsungen AG
10. Merit Medical Systems
11. Cook Medical
12. CONMED Corporation
13. Argon Medical Devices
14. Devicor Medical Products Inc.
15. QIAGEN N.V.
16. Pajunk
17. DTR Medical
18. INRAD, Inc.
19. Gallini Srl
20. TransMed7, LLC
21. MDL SRL
22. Sterylab S.r.l.
23. Zamar
24. Edgesmedicare
25. MedicalExpo